Your browser doesn't support javascript.
loading
Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery.
Liang, Shuli; Fan, Xing; Chen, Feng; Liu, Yonghong; Qiu, Binghui; Zhang, Kai; Qi, Songtao; Zhang, Guojun; Liu, Jinfang; Zhang, Jianguo; Wang, Jun; Wang, Xiu; Song, Ziyang; Luan, Guoming; Yang, Xuejun; Jiang, Rongcai; Zhang, Hua; Wang, Lei; You, Yongping; Shu, Kai; Lu, Xiaojie; Gao, Guoyi; Zhang, Bo; Zhou, Jian; Jin, Hai; Han, Kaiwei; Li, Yiming; Wei, Junji; Yang, Kun; You, Gan; Ji, Hongming; Jiang, Yuwu; Wang, Yi; Lin, Zhiguo; Li, Yan; Liu, Xuewu; Hu, Jie; Zhu, Junming; Li, Wenling; Wang, Yongxin; Kang, Dezhi; Feng, Hua; Liu, Tinghong; Chen, Xin; Pan, Yawen; Liu, Zhixiong; Li, Gang; Li, Yunqian; Ge, Ming; Fu, Xianming.
Afiliação
  • Liang S; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing 100045, China.
  • Fan X; Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Chen F; Xijing Hospital of Airforce Medical University, Xi'an, China.
  • Liu Y; Xijing Hospital of Airforce Medical University, Xi'an, China.
  • Qiu B; Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang K; Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Qi S; Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang G; Xijing Hospital of Airforce Medical University, Xi'an, China.
  • Liu J; Xiangya Hospital, Central South University, Changsha, China.
  • Zhang J; Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Wang J; Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wang X; Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Song Z; Xijing Hospital of Airforce Medical University, Xi'an, China.
  • Luan G; Sanbo Brain Hospital, Capital Medical University, Beijing, China.
  • Yang X; Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
  • Jiang R; Tianjin Medical University General Hospital, Tianjin, China.
  • Zhang H; Department of Neurosurgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
  • Wang L; Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • You Y; Jiangsu Provincial People's Hospital, Nanjing, China.
  • Shu K; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lu X; The Affiliated Hospital, Jiangnan University, Wuxi, China.
  • Gao G; Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Zhang B; Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Zhou J; Sanbo Brain Hospital, Capital Medical University, Beijing, China.
  • Jin H; General Hospital of Northern Theater Command, Shenyang, China.
  • Han K; Shanghai Changzheng Hospital, Shanghai Neurosurgical Institute, Shanghai, China.
  • Li Y; Shanghai Changzheng Hospital, Shanghai Neurosurgical Institute, Shanghai, China.
  • Wei J; Peking Union Medical College Hospital, Beijing, China.
  • Yang K; The First Affiliated Hospital, Hainan Medical University, Haikou, China.
  • You G; Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Ji H; Shanxi Provincial People's Hospital, Taiyuan, China.
  • Jiang Y; Peking University First Hospital, Beijing, China.
  • Wang Y; Children's Hospital of Fudan University, Shanghai, China.
  • Lin Z; First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Li Y; Children's Hospital of Soochow University, Suzhou, China.
  • Liu X; Department of Neurology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Institute of Epilepsy, Shandong University, Jinan, China.
  • Hu J; Huashan Hospital, Fudan University, Shanghai, China.
  • Zhu J; The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
  • Li W; The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wang Y; The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
  • Kang D; The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Feng H; The Southwest Hospital, Army Medical University, Chongqing, China.
  • Liu T; Xijing Hospital of Airforce Medical University, Xi'an, China.
  • Chen X; Tianjin Medical University General Hospital, Tianjin, China.
  • Pan Y; Lanzhou University Second Hospital, Lanzhou, China.
  • Liu Z; Xiangya Hospital, Central South University, Changsha, China.
  • Li G; Department of Neurology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Li Y; The First Hospital of Jilin University, Changchun, China.
  • Ge M; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.
  • Fu X; The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, China.
Ther Adv Neurol Disord ; 15: 17562864221114357, 2022.
Article em En | MEDLINE | ID: mdl-35992894
Seizures are a common symptom of craniocerebral diseases, and epilepsy is one of the comorbidities of craniocerebral diseases. However, how to rationally use anti-seizure medications (ASMs) in the perioperative period of craniocerebral surgery to control or avoid seizures and reduce their associated harm is a problem. The China Association Against Epilepsy (CAAE) united with the Trauma Group of the Chinese Neurosurgery Society, Glioma Professional Committee of the Chinese Anti-Cancer Association, Neuro-Oncology Branch of the Chinese Neuroscience Society, and Neurotraumatic Group of Chinese Trauma Society, and selected experts for consultancy regarding outcomes from evidence-based medicine in domestic and foreign literature. These experts referred to the existing research evidence, drug characteristics, Chinese FDA-approved indications, and expert experience, and finished the current guideline on the application of ASMs during the perioperative period of craniocerebral surgery, aiming to guide relevant clinical practice. This guideline consists of six sections: application scope of guideline, concepts of craniocerebral surgery-related seizures and epilepsy, postoperative application of ASMs in patients without seizures before surgery, application of ASMs in patients with seizures associated with lesions before surgery, emergency treatment of postoperative seizures, and 16 recommendations.
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Ther Adv Neurol Disord Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Ther Adv Neurol Disord Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China